Wanbury Limited
₹186.20▼ -4.86 (-2.54%)
WANBURY·NSE·Healthcare
Market Cap
672.62 Cr
PE Ratio
9.06
Volume
1,76,528
Day High - Low
196.46 - 184.99
52W High-Low
358.85 - 161.50
₹186.20▼ -4.86 (-2.54%)
Market Cap672.62 Cr
PE Ratio9.06
Volume1,76,528
Day High - Low196.46 - 184.99
52W High-Low358.85 - 161.50
Wanbury Limited (WANBURY): company summary
The company's annual revenue rose 8.4% to ₹650 crore, while net profit surged 113.3% to ₹66 crore.
Wanbury Limited (WANBURY) is a micro-cap Healthcare company valued at ₹673 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Wanbury Limited last traded at ₹186.2, down 2.54% on the day.
- Recent developments
- On 2026-07-21, Wanbury shares fell 7.6% intraday to ₹314.05, reflecting investor concerns despite recent financial improvements.
- Financial performance
- The company's annual revenue rose 8.4% to ₹650 crore, while net profit surged 113.3% to ₹66 crore. However, the latest quarter showed a sharp decline in net profit, falling 76.0% to ₹3 crore compared to ₹13 crore a year earlier, despite revenue increasing slightly by 1.5%.
- Valuation multiples
- The stock trades at 9.1 times earnings, a discount to the Healthcare median of 32.0, 5.86 times book value.
- Things to watch
- The company's latest quarter net profit dropped 76.0% year-over-year, and promoter shares pledged account for 62.18% of their holding, raising concerns about liquidity. The stock is 44.8% below its 52-week high, indicating a significant pullback from recent peak levels.
- Where it stands
- Wanbury Limited reported strong annual net profit growth of 113.3%, but the latest quarter saw a sharp decline in net profit. The stock is 44.8% below its 52-week high, and promoter shares pledged make up 62.18% of their holding.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
45.78%
Strong
P/E
9.06x
Cheap
Debt / Equity
1.49
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
Day₹184.99
₹196.46
52W₹161.50
₹358.85
DocStoX take
Supported by valuation (7.2) and quality (6.6), but held back by momentum (0.0).
DocStoX score
Low confidence4.5
/10
Weak
Quality
Solid
ROE 45.8%
Valuation
Fair
P/E 9.1×
Growth
Flat
Revenue +10.7% 5Y CAGR
Risk
Elevated
D/E 1.49
Momentum
Weak
13% of 52-week range
At a glance
Market Cap
₹673 Cr
52W High / Low
₹359 / ₹162
Dividend Yield
0.00%
Promoter Holding
43.02%
EPS (TTM)
₹20.55
Book Value
₹41.34
Key highlights
- Strong returns on equity (46%)
- Undemanding at 9× earnings
- Capital works hard — ROCE 25%
- Profit shrinking 0% a year
- 62% of promoter holding is pledged
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore WANBURY LIMITED’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
WANBURY LIMITED peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value WANBURY LIMITED with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing